LDL size: does it matter ?

Berneis, K.

Risultato della ricerca: Article

35 Citazioni (Scopus)

Abstract

The atherogenic lipoprotein phenotype is characterised by a moderate increase in plasma triglycerides, a decrease in high density lipoprotein cholesterol and the prevalence of smaller denser low density lipoprotein particles. The prevalence of this partially inheritable phenotype is approximately 30% and is a feature of the metabolic syndrome associated with an increased risk for cardiovascular events. The predominance of small dense LDL has been accepted as an emerging cardiovascular risk factor by the adult treatment panel (ATP) III.
Lingua originaleEnglish
pagine (da-a)720-724
Numero di pagine5
RivistaSwiss Medical Weekly
Volume134
Stato di pubblicazionePublished - 2004

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cita questo

Berneis, K. (2004). LDL size: does it matter ? Swiss Medical Weekly, 134, 720-724.

LDL size: does it matter ? / Berneis, K.

In: Swiss Medical Weekly, Vol. 134, 2004, pag. 720-724.

Risultato della ricerca: Article

Berneis, K. 2004, 'LDL size: does it matter ?', Swiss Medical Weekly, vol. 134, pagg. 720-724.
Berneis, K. LDL size: does it matter ? Swiss Medical Weekly. 2004;134:720-724.
Berneis, K. / LDL size: does it matter ?. In: Swiss Medical Weekly. 2004 ; Vol. 134. pagg. 720-724.
@article{4127fa5451fa42e58dd9dd18c95448e6,
title = "LDL size: does it matter ?",
abstract = "The atherogenic lipoprotein phenotype is characterised by a moderate increase in plasma triglycerides, a decrease in high density lipoprotein cholesterol and the prevalence of smaller denser low density lipoprotein particles. The prevalence of this partially inheritable phenotype is approximately 30{\%} and is a feature of the metabolic syndrome associated with an increased risk for cardiovascular events. The predominance of small dense LDL has been accepted as an emerging cardiovascular risk factor by the adult treatment panel (ATP) III.",
author = "{Berneis, K.} and Manfredi Rizzo",
year = "2004",
language = "English",
volume = "134",
pages = "720--724",
journal = "Swiss Medical Weekly",
issn = "1424-7860",
publisher = "EMH Swiss Medical Publishers Ltd.",

}

TY - JOUR

T1 - LDL size: does it matter ?

AU - Berneis, K.

AU - Rizzo, Manfredi

PY - 2004

Y1 - 2004

N2 - The atherogenic lipoprotein phenotype is characterised by a moderate increase in plasma triglycerides, a decrease in high density lipoprotein cholesterol and the prevalence of smaller denser low density lipoprotein particles. The prevalence of this partially inheritable phenotype is approximately 30% and is a feature of the metabolic syndrome associated with an increased risk for cardiovascular events. The predominance of small dense LDL has been accepted as an emerging cardiovascular risk factor by the adult treatment panel (ATP) III.

AB - The atherogenic lipoprotein phenotype is characterised by a moderate increase in plasma triglycerides, a decrease in high density lipoprotein cholesterol and the prevalence of smaller denser low density lipoprotein particles. The prevalence of this partially inheritable phenotype is approximately 30% and is a feature of the metabolic syndrome associated with an increased risk for cardiovascular events. The predominance of small dense LDL has been accepted as an emerging cardiovascular risk factor by the adult treatment panel (ATP) III.

UR - http://hdl.handle.net/10447/18577

M3 - Article

VL - 134

SP - 720

EP - 724

JO - Swiss Medical Weekly

JF - Swiss Medical Weekly

SN - 1424-7860

ER -

Accesso al documento